Washington,D.C.-based Danaher is continuing to augment its medical holdings.Now the firm is planning to acquire British lab equipment maker Genetix Group,PLC for 102 million dollars.Genetix has a specialty in imagery products that support drug,biologics and diagnostics development.The acquisition should be completed in Q1 of 2010,pending routine approvals.
Danaher also has extensive interests in dental imaging and instruments.Its board of directors has just appointed Dr.Elias A. Zerhouni,M.D. to the board.Dr.Zerhouni is an expert in medical research,radiology and bioengineering.The board feels that Dr.Zerhouni,who has been associated with Johns Hopkins University and the National Institutes of Health,will be an insightful and valuable contributor,especially given Danaher's growing presence in medical technologies.He is a graduate of the University of Algiers.
No comments:
Post a Comment